Caren Deardorf

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Tobin Schilke, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caren Deardorf:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 16,300 $543,116 $33.32 11 Jun 2025 Direct
Magenta Therapeutics, Inc. Chief Commercial Officer Common Stock 19,762 $237,144 $12.00 30 Nov 2022 Direct
Magenta Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 75,000 01 Aug 2022 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 10,350 11 Jun 2025 Direct

Insider Reports Filed by Caren Deardorf

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 07 Jun 2024 2 $0 4 Director 11 Jun 2024, 16:21
CRNX Crinetics Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:00
DNTH Magenta Therapeutics, Inc. 30 Nov 2022 1 +$2,820 4 Chief Commercial Officer 02 Dec 2022, 15:23
DNTH Magenta Therapeutics, Inc. 01 Aug 2022 1 $0 4 Chief Commercial Officer 01 Aug 2022, 21:10
CRNX Crinetics Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:45
DNTH Magenta Therapeutics, Inc. 31 May 2022 1 +$2,970 4 Chief Commercial Officer 06 Jun 2022, 16:05
DNTH Magenta Therapeutics, Inc. 17 May 2022 1 $0 4 Chief Commercial Officer 19 May 2022, 16:17
CRNX Crinetics Pharmaceuticals, Inc. 11 Mar 2022 1 $0 4/A Director 04 Apr 2022, 19:09
CRNX Crinetics Pharmaceuticals, Inc. 11 Mar 2022 0 $0 3 Director 14 Mar 2022, 17:18
DNTH Magenta Therapeutics, Inc. 15 Feb 2022 1 $0 4 Chief Commercial Officer 17 Feb 2022, 16:20
DNTH Magenta Therapeutics, Inc. 16 Sep 2021 1 -$41,982 4 Chief Commercial Officer 20 Sep 2021, 17:02
DNTH Magenta Therapeutics, Inc. 14 Sep 2021 1 $0 4 Chief Commercial Officer 16 Sep 2021, 19:41
DNTH Magenta Therapeutics, Inc. 06 Jul 2021 1 $0 4 Chief Commercial Officer 08 Jul 2021, 16:33
DNTH Magenta Therapeutics, Inc. 06 Jul 2021 0 $0 3 Chief Commercial Officer 08 Jul 2021, 16:32